Financials HealthStream, Inc.

Equities

HSTM

US42222N1037

Software

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
25.61 USD -1.20% Intraday chart for HealthStream, Inc. +3.10% -5.25%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 880.7 691.8 832 759.4 818.6 778.5 - -
Enterprise Value (EV) 1 880.7 691.8 832 759.4 818.6 778.5 778.5 778.5
P/E ratio 55.5 x 49.6 x 146 x 63.7 x 54.1 x 46.8 x 42.6 x -
Yield - - - - 0.37% 0.43% 0.43% -
Capitalization / Revenue 3.47 x 2.83 x 3.24 x 2.85 x 2.93 x 2.65 x 2.51 x 2.36 x
EV / Revenue 3.47 x 2.83 x 3.24 x 2.85 x 2.93 x 2.65 x 2.51 x 2.36 x
EV / EBITDA 18.8 x 15 x 15.8 x 14.2 x 13.4 x 11.8 x 11.1 x -
EV / FCF 30.2 x 20.4 x 48.8 x 14.8 x 22.8 x 30.7 x 27.5 x 23.1 x
FCF Yield 3.31% 4.9% 2.05% 6.74% 4.39% 3.25% 3.63% 4.33%
Price to Book 2.6 x - - - - - - -
Nbr of stocks (in thousands) 32,378 31,678 31,562 30,573 30,285 30,398 - -
Reference price 2 27.20 21.84 26.36 24.84 27.03 25.61 25.61 25.61
Announcement Date 18/02/20 22/02/21 21/02/22 20/02/23 19/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 254.1 244.8 256.7 266.8 279.1 294.1 309.9 330.4
EBITDA 1 46.87 45.99 52.68 53.44 61.3 66.08 69.96 -
EBIT 1 14.72 15.82 8.055 12.45 16.02 19.07 20.63 23.79
Operating Margin 5.79% 6.46% 3.14% 4.67% 5.74% 6.48% 6.66% 7.2%
Earnings before Tax (EBT) 1 17.93 17.82 7.766 15.58 18.51 22.23 24.27 -
Net income 1 15.77 14.09 5.845 12.09 15.21 16.8 18.29 -
Net margin 6.21% 5.76% 2.28% 4.53% 5.45% 5.71% 5.9% -
EPS 2 0.4900 0.4400 0.1800 0.3900 0.5000 0.5467 0.6017 -
Free Cash Flow 1 29.15 33.89 17.04 51.19 35.96 25.32 28.3 33.73
FCF margin 11.47% 13.84% 6.64% 19.18% 12.89% 8.61% 9.13% 10.21%
FCF Conversion (EBITDA) 62.18% 73.69% 32.34% 95.78% 58.67% 38.31% 40.44% -
FCF Conversion (Net income) 184.83% 240.48% 291.51% 423.36% 236.4% 150.68% 154.67% -
Dividend per Share 2 - - - - 0.1000 0.1100 0.1100 -
Announcement Date 18/02/20 22/02/21 21/02/22 20/02/23 19/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 64.34 65.37 65.64 67.28 68.54 68.95 69.2 70.34 70.58 72.76 72.85 73.96 74.5 76.14 76.7
EBITDA 1 12.04 13.97 13.13 12.74 13.62 13.73 15.35 16.24 15.98 17.06 16.06 16.28 16.7 16.84 17.02
EBIT 1 -0.46 4.035 2.953 2.382 3.079 2.891 4.008 4.863 4.256 5.69 4.354 4.417 4.604 4.892 4.676
Operating Margin -0.71% 6.17% 4.5% 3.54% 4.49% 4.19% 5.79% 6.91% 6.03% 7.82% 5.98% 5.97% 6.18% 6.42% 6.1%
Earnings before Tax (EBT) 1 -0.499 3.759 3.632 4.925 3.27 3.141 4.5 5.453 5.418 6.543 5.087 5.186 5.41 5.759 5.571
Net income 1 -0.387 2.893 3.083 3.666 2.451 2.623 4.133 3.867 4.59 5.227 3.76 3.831 3.986 4.404 4.258
Net margin -0.6% 4.43% 4.7% 5.45% 3.58% 3.8% 5.97% 5.5% 6.5% 7.18% 5.16% 5.18% 5.35% 5.78% 5.55%
EPS 2 -0.0100 0.0900 0.1000 0.1200 0.0800 0.0900 0.1300 0.1300 0.1500 0.1700 0.1233 0.1283 0.1333 0.1400 0.1350
Dividend per Share 2 - - - - - - - 0.0250 0.0250 - 0.0300 0.0300 0.0300 0.0300 0.0300
Announcement Date 21/02/22 25/04/22 25/07/22 24/10/22 20/02/23 24/04/23 24/07/23 23/10/23 19/02/24 22/04/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 29.1 33.9 17 51.2 36 25.3 28.3 33.7
ROE (net income / shareholders' equity) 4.8% - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 10.40 - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 22 - - - 28 29.7 29.5 31
Capex / Sales 8.66% - - - 10.04% 10.1% 9.52% 9.38%
Announcement Date 18/02/20 22/02/21 21/02/22 20/02/23 19/02/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
25.61 USD
Average target price
31.67 USD
Spread / Average Target
+23.65%
Consensus
  1. Stock Market
  2. Equities
  3. HSTM Stock
  4. Financials HealthStream, Inc.